IL-7 and Flt-3L plasma levels are increased during highly active antiretroviral therapy-associated IL-2 therapy

AIDS

Volumn 18, Issue 15, 2004, Pages 2089-2091

  Beq, Stéphanie ^a   Fontanet, Arnaud ^a   Theze, Jacques ^a   Colle, Jean Hervé ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FLT3 LIGAND; INTERLEUKIN 2; INTERLEUKIN 7; PROTEIN BCL 2;

ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; LYMPHOPOIESIS; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FMS-LIKE TYROSINE KINASE 3; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; INTERLEUKIN-7; LYMPHOPENIA; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES; STEM CELL FACTOR;

EID: 7744240330     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200410210-00016     Document Type: Article

References (6)

1. Allende MC, Lane HC. Cytokine-based therapies for HIV infection. AIDS 2001; 15 (Suppl. 5):S183-S191.
2. + patients whose CD4 cell counts fail to increase rapidly in response to HAART. AIDS 2002; 16:1093-1101.
3. Sereti I, Martinez-Wilson H, Metcalf JA, Baseler MW, Hallahan CW, Hahn B, et al. Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection/characterization of novel subsets of CD4+/CD25+ T cells. Blood 2002; 100:2159-2167.
4. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood 2001; 99:3892-3904.
5. Lyman SD, Jacobsen SEW. c-kit ligand and Flt-3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998; 91:1101-1134.
6. Carcelain G, Saint-Mézard P, Altes HK, Tubiana R, Grenot P, Rabian C, et al. IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia. AIDS 2003; 17:841-850.